Insulin aspart, recombinant Subcutaneous and Ondansetron Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ondansetron Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: Ondansetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ondansetron injection
- Insulin aspart, recombinant Subcutaneous-Ondansetron ODT
- Insulin aspart, recombinant Subcutaneous-Ondansetron Oral Soluble Film
- Insulin aspart, recombinant Subcutaneous-Ondansetron Oral Solution
- Insulin aspart, recombinant Subcutaneous-Ondansetron Oral, Injection, Intravenous
- Insulin aspart, recombinant Subcutaneous-Ondansetron Oral, Oromucosal
- Ondansetron Hydrochloride-Insulin degludec
- Ondansetron Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Ondansetron Hydrochloride-Insulin Degludec (U-100) Vials
- Ondansetron Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Ondansetron Hydrochloride-Insulin degludec and liraglutide
- Ondansetron Hydrochloride-Insulin degludec and liraglutide Subcutaneous